Pfizer Covid vaccine clears Japan panel for use with young children

A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc's Covid-19 vaccine for children as young as six months old.

Japan in January expanded use of the vaccine to those as young as five years old. Last month, health authorities started dispensing Pfizer and Moderna Inc booster shots that target the Omicron variant of the virus.

Recommended For You

Jordan shoots down 5 missiles launched from Iran; no injuries reported

Iran must 'pay price', has taken too long to negotiate deal, says Trump

US is going to hit Iran hard again today, says Trump

Iran says 2 ships hit in Hormuz, US Fifth fleet targeted in Bahrain

Strait of Hormuz closed 'until further notice' after US strikes: PGSA

 

The panel also recommended approval of a version of the Pfizer vaccine that protects against the BA.4 and BA.5 subvariants of Omicron. Moderna said earlier on Wednesday it was seeking Japanese approval of its own subvariant shot.

ALSO READ:

UAE fights Covid: Abu Dhabi achieves world's highest vaccination rate at almost 100%

Covid 19: French drugmaker Valneva in talks with potential partner on second-gen vaccines

EU watchdog approves vaccine targeting Omicron sub-variants